These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38735538)

  • 1. Quantitative Proteomic Analysis Reveals Functional Alterations of the Peripheral Immune System in Colorectal Cancer.
    Zhu W; Li M; Wang Q; Shen J; Ji J
    Mol Cell Proteomics; 2024 Jun; 23(6):100784. PubMed ID: 38735538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer.
    Yang SB; Du Y; Wu BY; Xu SP; Wen JB; Zhu M; Cai CH; Yang PC
    Cancer Immunol Immunother; 2012 Mar; 61(3):335-42. PubMed ID: 21913024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in circulating lymphocyte subpopulations among patients with inflammatory polyps, colorectal adenomas and colorectal cancer.
    Zheng J; Jin H; Tu Y
    Arab J Gastroenterol; 2024 May; 25(2):129-134. PubMed ID: 38413325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
    Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
    Front Immunol; 2019; 10():2936. PubMed ID: 31921188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab Enhanced the Cytotoxic Activity of Immune Cells during Treatment of Colorectal Cancer.
    Wang L; Wei Y; Fang W; Lu C; Chen J; Cui G; Diao H
    Cell Physiol Biochem; 2017; 44(3):1038-1050. PubMed ID: 29179214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer.
    Xu B; Yuan L; Gao Q; Yuan P; Zhao P; Yuan H; Fan H; Li T; Qin P; Han L; Fang W; Suo Z
    Oncotarget; 2015 Aug; 6(24):20592-603. PubMed ID: 26008981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study.
    Cheng YK; Chen DW; Chen P; He X; Li PS; Lin ZS; Chen SX; Ye SB; Lan P
    Front Immunol; 2022; 13():809971. PubMed ID: 35185898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
    Lalos A; Tülek A; Tosti N; Mechera R; Wilhelm A; Soysal S; Daester S; Kancherla V; Weixler B; Spagnoli GC; Eppenberger-Castori S; Terracciano L; Piscuoglio S; von Flüe M; Posabella A; Droeser RA
    Sci Rep; 2021 Jan; 11(1):775. PubMed ID: 33436863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Proteomic Coverage in Tissue Microenvironment by Immune Cell Subtype Library-Assisted DIA-MS.
    Yang JC; Hsu TH; Chen CS; Yu JH; Lin KI; Chen YJ
    Mol Cell Proteomics; 2024 Jul; 23(7):100792. PubMed ID: 38810695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between IFNAR1 expression in peripheral blood T lymphocytes and inflammatory cytokines, tumor-infiltrating lymphocytes, and chemosensitivity in patients with colorectal cancer.
    Yang L; Zhang X; Huang X; Dong X; Jing S; Zhang Y; Zhao B; Wang Z; Qu H
    Cytokine; 2022 Nov; 159():156008. PubMed ID: 36063748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling.
    Sun X; Liu S; Wang D; Zhang Y; Li W; Guo Y; Zhang H; Suo J
    Oncotarget; 2017 Feb; 8(9):15168-15181. PubMed ID: 28147310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol induction in CD8
    Shuwen H; Yinhang W; Jing Z; Qiang Y; Yizhen J; Quan Q; Yin J; Jiang L; Xi Y
    Cancer Immunol Immunother; 2023 Dec; 72(12):4441-4456. PubMed ID: 37919522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors.
    Maccalli C; Scaramuzza S; Parmiani G
    Cancer Immunol Immunother; 2009 May; 58(5):801-8. PubMed ID: 19089424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry.
    Zhou C; Wang Z; Jiang B; Di J; Su X
    Front Immunol; 2022; 13():807539. PubMed ID: 35185893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
    Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
    Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.